Bibliography
- GEORGOPAPADAKOU NF: Update on antifungals targeted to the cell wall: focus on 3-1,3-glucan synthase inhibitors. Expert Opin. Investig. Drugs (2001) 10(2):269–280.
- •Good, recent review on antifungals and the P-glucan inhibitors.
- MASUBUCHI K, OKADA T, KOHCHI M etal.: Synthesis and antifungal activities of novel 1,3-13-D-glucan synthase inhibitors. Part 1. Bioorg. Med. Chem. Lett. (2001) 11:395–398.
- ••Contains much of the information, and compound information used in the generation of the reviewed patents.
- MASUBUCHI K, OKADA T, KOHCHI M et al: Synthesis and antifungal activities of novel 1,3-13-D-glucan synthase inhibitors. Part 2. Bioorg. Med. Chem. Lett. (2001) 11:1273–1276.
- ••Contains much of the information, and compound information used in the generation of the reviewed patents.
- TSUKUDA T et al.: Modeling, synthesis and biological activity of novel antifungal agents. Bioorg. Med. Chem. Lett. (1998) 8:1819–1824.
- ••Excellent SAR approach to thehexapeptides.
- HECTOR RF: Compounds active against cell walls of medically important fungi. Clin. Microbial. Rev (1993) 6(1):1–21.
- •Review article on antifungal compounds targeting the cell wall.
- KRISHNARAO TV, GALGIANI JN: of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. Antimicrob. Agents Chemother. (1997) 41:1957–1960.
- BARCHIESI F, SCHIMIZZI AM, FOTHERGILL AW, SCALISE G, RINALDI MG: In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species. Eur. j Clin. Microbial. Infect. Dis. (1999) 18:302–304.
- MOORE CB, OAKLEY KL, DENNING DW In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species. 11/licrobioL Infect. (2001) 7:11–16.
- MIKAMO H, SATO Y, TAMAYA T: In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide. j Antimicrob. Chemother. (2000) 46:485–487.
- ESPINEL-INGROFF A: Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. j Gun. Microbial. (1998) 36:2950–2956.
- •Good comparative in vitro study of the two leading echinocandirts and one of the newer azoles versus a wide variety of medically important yeast, dimorphics and filamentous fungi.
- PFALLER MA, MARCO F, MESSER SA, JONES RN: In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn. Microbial. Infect. Dis. (1998) 30:251–255.
- •Good in vitro study of the echirtocandins against a wide variety of filamentous fungi.
- GRAYBILL JR:. Changing strategies for treatment of systemic mycoses. Biz. Infect. Dis. (2000) 4(2):47–54.
- STEVENS DA: Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens. Antimicrob. Agents Chemother. (2000) 44:2547–2548.
- ••This paper describes the rather dramatic seen with the combination of [3-glucan and chitin synthase inhibitors.
- GANESAN LT, MANAVATHU EK, CUTRIGHT JL, CHANDRASEKAR PH: In vitro synergy of a combination of nikkomycin plus echinocandin against Aspergillus fumigatus. Abstract 649, 39th Annual Meeting of the Infectious Disease Society of America.
- CHIOU CC, MAVROGIORGOS N, TILLEM E, HECTOR R, WALSH TJ. Synergy, pharmacodynamics, and time-sequenced ultrastrctural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus. Antimicrob. Agents Chemo. (2001) 45:3310–3321.
- ••Paper describing the rather dramaticsynergy seen with the combination of [3-glucan and chitin synthase inhibitors.